ExcitingAds! In

Three HS Studies of Different Targeted Rxs Are Positive

Sat, 3 Oct 2026 14:23:01 EDT

Three controlled trials evaluating different investigational treatments for hidradenitis suppurativa identify new targets capable of interrupting disease pathophysiology.

Experts Urge Defense Against AI Cyberattacks on Healthcare

Fri, 2 Oct 2026 15:05:30 EDT

What does the OpenAI agent’s recent hacking of an Australian government healthcare website mean for the future of cybersecurity?

Five Bloating Mechanisms: Are You Treating the Right One?

Fri, 2 Oct 2026 14:49:26 EDT

Most patients with bloating have overlapping mechanisms. Dr Muratore breaks down the 5 pathophysiologic drivers — and how to identify which one to treat first.

How Old Are You?

Fri, 2 Oct 2026 14:25:57 EDT

Patient doubts about your capabilities can bookend a doctor’s career. You go from looking too young to know enough to looking too old to be up to date.

The Price of Forgetting Measles

Fri, 2 Oct 2026 14:12:15 EDT

Dr Daskalakis explains the societal and economic impact that Americans may be faced with if eliminated diseases revert to endemic outbreaks.

Conference MDAngle: AAO 2026 Wet Age-Related Macular Degeneration

Fri, 2 Oct 2026 13:07:34 EDT

Upcoming presentations on emerging wet AMD treatment strategies, including TKI, gene therapy, and personalized anti-VEGF therapy.

AAO 2026 Preview: Emerging Therapies for Wet AMD

Fri, 2 Oct 2026 12:56:22 EDT

Anticipated presentations on emerging wet AMD treatment strategies, including TKI, gene therapy, and individualized anti-VEGF therapy.

Breaking Up Sedentary Time With Exercise Snacks

Fri, 2 Oct 2026 11:59:47 EDT

Hungry for a health hack? Dr Neil Skolnik explores how 5-minute 'exercise snacks' combat the adverse health risks of our modern sedentary lives.

England Extends Free Flu Vaccination to Homeless People

Fri, 2 Oct 2026 11:16:23 EDT

Pop-up clinics and mobile vans will take vaccination to rough-sleeping hotspots, with GP registration possible without proof of address.

New IL-4 Inhibitor Found Effective for Prurigo Nodularis

Fri, 2 Oct 2026 11:12:33 EDT

In a phase 3 trial, oturkibart, a humanized monoclonal antibody that binds to the IL-4 receptor, was efficacious and safe for prurigo nodularis at 52 weeks.

HCTZ May Raise Your Patient’s Skin Cancer Risk

Fri, 2 Oct 2026 10:22:25 EDT

The FDA flagged hydrochlorothiazide for increasing nonmelanoma skin cancer risk. Learn which patients are most vulnerable and what alternative treatments to consider.

Ovarian Cancer Mortality Risk Drops to Normal at 10 Years

Fri, 2 Oct 2026 10:06:40 EDT

Can ovarian cancer be cured? Dr Maurie Markman reviews landmark data showing normal life expectancy 10 years post-diagnosis.

Consent Not Needed for Brain Death Testing, Says Ethicist

Fri, 2 Oct 2026 08:51:53 EDT

Ethicist Art Caplan discusses considerations for brain death testing and whether consent is needed.

Are Paediatric IBD Diagnostic Pathways Often Inappropriate?

Fri, 2 Oct 2026 08:00:00 EDT

Diagnostic pathways are often inappropriate in paediatric inflammatory bowel disease, with many cases bypassing proper evaluation; severe intestinal symptoms are linked to appropriate pathways.

Upadacitinib Hits JAKPPPOT in Palmoplantar Pustulosis Trial

Fri, 2 Oct 2026 06:48:59 EDT

JAK inhibitor treatment using upadacitinib reduces disease severity in palmoplantar pustulosis, warranting further study.

Most School-Leavers in England Yet to Have First MenB Dose

Fri, 2 Oct 2026 04:56:16 EDT

Wide gaps in uptake by region, sex, deprivation, and ethnicity have been noted as the UK Health Security Agency urges students to book both doses.

Photon-Counting CT Reduces Calcium Overestimation vs EID CT

Fri, 2 Oct 2026 12:00:00 EDT

A brief report comparing PCCT and EID CT for the assessment of stenosis severity in human cadaveric coronary arteries

Medscape Private-Payer and Government Insurance Report 2026

Fri, 2 Oct 2026 12:00:00 EDT

From reimbursement rates to prior authorization, US physicians share their insights, thoughts, and frustrations with private-payer insurance as well as with Medicare and Medicaid.

Phage Therapy: New Guidelines and Unanswered Questions

Fri, 2 Oct 2026 12:00:00 EDT

A new consensus guideline outlines how phages should be selected, prepared, and monitored, while clinical evidence remains insufficient to support routine use.

Metformin in Pregnancy Poses No Child Neuro Risk

Fri, 2 Oct 2026 12:00:00 EDT

In-utero metformin exposure carries no neurodevelopmental risk for children by age 5, offering key safety data for managing diabetes in pregnancy, a study shows.